相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。
Article
Oncology
The oral NK1 antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy:: a combined analysis of two randomised, placebo-controlled phase III clinical trials
R de Wit et al.
EUROPEAN JOURNAL OF CANCER (2004)
分享论文
